
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.69 | 2.66924564797 | 25.85 | 26.78 | 25.06 | 9030292 | 25.67381008 | CS |
4 | -0.29 | -1.08087961237 | 26.83 | 29.19 | 25.06 | 10709963 | 26.74239406 | CS |
12 | -2.16 | -7.52613240418 | 28.7 | 30.3 | 23.15 | 10856567 | 26.18649446 | CS |
26 | -13.05 | -32.9628694115 | 39.59 | 48.92 | 23.15 | 10941032 | 31.23920574 | CS |
52 | -108.03 | -80.2779222709 | 134.57 | 138.07 | 23.15 | 8468271 | 42.70897856 | CS |
156 | -117.45 | -81.5681644559 | 143.99 | 217.25 | 23.15 | 5685649 | 87.58150453 | CS |
260 | -36.69 | -58.0262533607 | 63.23 | 497.17 | 23.15 | 8786846 | 149.93612839 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.